Related Experiment Video
Updated: Jun 25, 2026

Rapid Analysis of Circadian Phenotypes in Arabidopsis Protoplasts Transfected with a Luminescent Clock Reporter
Published on: September 17, 2016
A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53
Jasper Mullenders1, Armida W M Fabius, Mandy Madiredjo
1Division of Molecular Carcinogenesis, Centre for Biomedical Genetics and Cancer Genomics Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Background:
The p53 tumor suppressor gene is mutated in about half of human cancers, but the p53 pathway is thought to be functionally inactivated in the vast majority of cancer. Understanding how tumor cells can become insensitive to p53 activation is therefore of major importance. Using an RNAi-based genetic screen, we have identified three novel genes that regulate p53 function.
Results:
We have screened the NKI shRNA library targeting 8,000 human genes to identify modulators of p53 function. Using the shRNA barcode technique we were able to quickly identify active shRNA vectors from a complex mixture. Validation of the screening results indicates that the shRNA barcode technique can reliable identify active shRNA vectors from a complex pool. Using this approach we have identified three genes, ARNTL, RBCK1 and TNIP1, previously unknown to regulate p53 function. Importantly, ARNTL (BMAL1) is an established component of the circadian regulatory network. The latter finding adds to recent observations that link circadian rhythm to the cell cycle and cancer. We show that cells having suppressed ARNTL are unable to arrest upon p53 activation associated with an inability to activate the p53 target gene p21(CIP1).
Conclusions:
We identified three new regulators of the p53 pathway through a functional genetic screen. The identification of the circadian core component ARNTL strengthens the link between circadian rhythm and cancer.
Insights
Researchers identified three new genes regulating the p53 pathway, including ARNTL (BMAL1), a circadian clock component. This discovery strengthens the link between circadian rhythm and cancer progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The p53 tumor suppressor gene is frequently mutated or inactivated in human cancers.
- Understanding mechanisms of p53 pathway inactivation is crucial for cancer therapy.
- Identifying novel regulators of p53 function can reveal new therapeutic targets.
Purpose of the Study:
- To identify novel genes that regulate the p53 tumor suppressor pathway.
- To investigate the role of these newly identified genes in cancer.
Main Methods:
- A large-scale RNA interference (RNAi)-based genetic screen using an shRNA library targeting 8,000 human genes.
- Utilized the shRNA barcode technique for efficient identification of active shRNA vectors.
- Functional validation of identified genes in cancer cells.
Main Results:
- Identified three previously unknown regulators of p53 function: ARNTL, RBCK1, and TNIP1.
- ARNTL (also known as BMAL1) is a core component of the circadian regulatory network.
- Suppression of ARNTL impairs p53-mediated cell cycle arrest and p21 activation.
Conclusions:
- Discovered three novel regulators of the p53 pathway.
- The identification of ARNTL highlights a significant connection between circadian rhythm and cancer.
- Findings provide new insights into p53 pathway regulation and its role in cancer development.
More Related Videos
11:56In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells
Published on: September 28, 2017
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Circadian Rhythms and Gene Regulation
Circadian Rhythms and Gene Regulation
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle